Table III.
Distribution frequency of miRNA-binding SNPs between GC patients and healthy controls.
| Variant | Gene | Genotype | Cases | Controls | P-value | OR | 95% CI |
|---|---|---|---|---|---|---|---|
| rs1044129 | RYR3 | AA | 47 | 67 | 0.679 | 1.099 | 0.704–1.715 |
| AG+GG | 106 | 166 | |||||
| rs1053667 | KIAA0423 | TT | 113 | 161 | 0.314 | 1.263 | 0.801–1.992 |
| CT+CC | 40 | 72 | |||||
| rs4901706 | C14orf101 | GG | 100 | 125 | 0.022 | 1.630 | 1.070–2.483 |
| AG+AA | 53 | 108 | |||||
| rs11337 | GOLGA7 | GG | 92 | 141 | 0.940 | 0.984 | 0.649–1.493 |
| GT+TT | 61 | 92 | |||||
| rs3660 | KRT81 | GG | 97 | 145 | 0.917 | 1.023 | 0.662–1.583 |
| CG+CC | 56 | 88 |
miRNA, microRNA; SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval.